CHRISTIAN KLEIN,DANIEL ALEXANDER HEINRICH,FRANK HERTING,MARTIN DREYLING
申请号：
BR112012003066
公开号：
BR112012003066A2
申请日:
2010.08.12
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody with fludarabine and/or mitoxantrone.
